CalciMedica Reports Third Quarter 2026 Financial Results and Provides Clinical & Corporate UpdatesGlobeNewsWire • Tuesday
CalciMedica to Participate in the Guggenheim 3rd Annual Healthcare Innovation ConferenceGlobeNewsWire • 11/03/26
CalciMedica to Participate in the H.C. Wainwright 28th Annual Global Investment ConferenceGlobeNewsWire • 09/08/26
CalciMedica Announces FDA Alignment on Phase 2b Trial Design for Auxora in Acute Pancreatitis and Identifies Disease's First Potential Registrational EndpointsPRNewsWire • 07/29/26
CalciMedica Announces Private Placement Financing for Up to Approximately $49 Million to Advance Pulmonary Hypertension ProgramPRNewsWire • 06/24/26
CalciMedica Announces Clinical Development of Auxora May Proceed Following FDA Review of KOURAGE Trial Interim Safety DataPRNewsWire • 06/24/26
CalciMedica Reports First Quarter 2026 Financial Results and Provides Clinical & Corporate UpdatesPRNewsWire • 05/12/26
CalciMedica Announces Discontinuation of Phase 2 KOURAGE Trial in AKI Following Independent Data Monitoring Committee RecommendationPRNewsWire • 01/28/26
CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical & Corporate UpdatesPRNewsWire • 11/12/25
CalciMedica Announces Publication in JCI Insight of Preclinical Data Supporting CRAC Channel Inhibitor as a Potential Therapy for Pulmonary Arterial HypertensionPRNewsWire • 11/12/25
CalciMedica Presents Data from Preclinical Study of Auxora™ in an Animal Model of AKI at ASN Kidney Week 2025PRNewsWire • 11/10/25
CalciMedica and Telperian Announce Collaboration to Integrate Innovative Artificial Intelligence Engine to Analysis of Clinical Trials of Auxora™PRNewsWire • 10/14/25
CalciMedica to Participate in the H.C. Wainwright 27th Annual Global Investment ConferencePRNewsWire • 09/02/25
CalciMedica Reports Second Quarter 2025 Financial Results and Provides Clinical & Corporate UpdatesPRNewsWire • 08/12/25
CalciMedica to Participate in the H.C. Wainwright 4th Annual Kidney Virtual ConferencePRNewsWire • 07/08/25
CalciMedica Announces Publication in the American Journal of Nephrology Discussing Design and Rationale of Phase 2 KOURAGE Trial of Auxora™ in AKI with Respiratory FailurePRNewsWire • 06/25/25
CalciMedica Announces Upcoming Symposium at the 43rd Vicenza Course AKI-CRRT-EBPT and Critical Care Nephrology MeetingPRNewsWire • 06/12/25
CalciMedica Reports First Quarter 2025 Financial Results and Provides Clinical & Corporate UpdatesPRNewsWire • 05/14/25
CalciMedica Inc. (CALC) Moves to Buy: Rationale Behind the UpgradeZacks Investment Research • 04/02/25
CalciMedica to Participate in the Jones Healthcare and Technology Innovation ConferencePRNewsWire • 04/01/25